Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Campath litigation germany?Generic brand for latisse?Drug patent watch trametinib?Dabrafenib patent expiration date novartis gsk composition matter?Mebendazole ingredients?
See the DrugPatentWatch profile for Amvuttra
The information provided here doesn’t include Amvuttra (vutrisiran) marketing authorization dates, so I can’t verify the specific authorization date in 2022 from the sources available.
Marketing authorization dates differ by regulator (for example, EMA vs. FDA) and by procedure (e.g., accelerated review). If you tell me the region/regulator you mean (EMA specifically, or another authority), I can narrow the answer to the correct date.
“Marketing authorization date” usually refers to the regulator’s approval date, not the first marketed product availability date. If you confirm which one you need, I can give the exact date accordingly.
Other Questions About Amvuttra :